FXHvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with FXH, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FXH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/17/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FXH ETF 2 | +0.53%– | +13.98%– | +16.21%– | +22.70%– | +33.57%– | +7.15%– |
| Flows | FXH ETF 2 | +$20M– | +$120M– | +$65M– | +$44M– | -$498M– | -$437M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FXH ETF 2 | +15.66%– | +15.54%– | +15.63%– | +16.94%– |
| Max drawdown | FXH ETF 2 | -4.40%– | -12.07%– | -17.66%– | -28.28%– |
| Max drawdown duration | FXH ETF 2 | 23d– | 168d– | 395d– | 1742d– |
Trading data
FXH | ETF 2 | |
Last sale 9/18/2026 at 1:30 PM | $130.77 | – |
| Previous close 09/17/2026 | $131.56 | – |
| Consolidated volume 09/17/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
FXH | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/18/2026 at 1:30 PM
Live
Closed
FXH | ETF 2 | |
|---|---|---|
| Last price | $130.77 | – |
| 1D performance | -0.60% | – |
| AuM | $1.15 B | – |
| E/R | 0.61% | – |
Characteristics
FXH | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | First Trust | – |
| Benchmark | StrataQuant Health Care Index | – |
| N° of holdings | 72 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | May 8, 2007 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
FXH
USA
93.07%
Other
6.93%
ETF 2
Sectors
FXH
Healthcare
98.24%
Other
1.76%
ETF 2
Diversification
FXH
Total weight of top 15 holdings out of 15
35.54%
ETF 2
–
Top 15 holdings
Data as of July 31, 2026
FXH
Regeneron Pharmaceuticals, Inc.
2.85%
Natera, Inc.
2.57%
Universal Health Services, Inc.
2.50%
Boston Scientific Corp.
2.49%
Pfizer Inc.
2.48%
Zimmer Biomet Holdings, Inc.
2.47%
Solventum Corp.
2.47%
Guardant Health, Inc.
2.41%
Tenet Healthcare Corp.
2.34%
Globus Medical, Inc.
2.33%
Corcept Therapeutics, Inc.
2.24%
Halozyme Therapeutics, Inc.
2.18%
Centene Corp.
2.15%
The Cigna Group
2.14%
Encompass Health Corp.
1.92%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
